HIV/AIDS

Use of antiretrovirals for treatment and prevention of HIV infection

WHO

Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering when use is made of a potent ARV regimen, particularly in early stages of the disease.

Since 2013, WHO also recommends the ARV use for the prevention of HIV infection, particularly for pregnant women, young children, and key populations exposed to HIV risk. Countries are now following to adapt and implement these recommendations within own epidemiological settings.

WHO is also working to improve scaling up of ARV use in developing countries by optimizing drugs and diagnostics and enhancing community engagement.

Latest updates

Normative guidelines and reports

Events and meetings

Global Health Sector Strategy on HIV/AIDS 2011-2015: Let’s do what’s right for everyone

Global Hepatitis Programme

Contact us

World Health Organization
HIV/AIDS Department
20, Avenue Appia
CH-1211 Geneva 27
Switzerland
Email: hiv-aids@who.int